FILE:FLR/FLR-8K-20050713141753.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
Table of Contents
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
Table of Contents
Item 5.02(d). Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
     Fluor Corporation is filing this amendment to its Current Report on Form 8-K dated April 27, 2005, which included a report that Dr. Peter S. Watson had been appointed to the Board of Directors of Fluor Corporation.
     On July 12, 2005, the Board of Directors of Fluor Corporation affirmatively determined that Dr. Watson was independent of Fluor Corporation and its management under the standards set forth in the Fluor Corporation and in Sections 303A.02(a) and 303A.02(b) of the New York Stock Exchange Listed Company Manual, and appointed Dr. Watson as a member of the Governance Committee of the Board of Directors.
Corporate Governance Guidelines
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


